US equities
|
GOOGL
$324.89
▲+0.00%
GOOG
$321.89
▲+0.00%
MSFT
$531.01
▲+0.00%
MU
$983.23
▲+0.00%
LITE
$913.95
▲+0.00%
MRVL
$251.65
▲+0.00%
SNDK
$1,404.77
▲+0.00%
AMZN
$254.60
▲+0.00%
GOOGL
$324.89
▲+0.00%
GOOG
$321.89
▲+0.00%
MSFT
$531.01
▲+0.00%
MU
$983.23
▲+0.00%
LITE
$913.95
▲+0.00%
MRVL
$251.65
▲+0.00%
SNDK
$1,404.77
▲+0.00%
AMZN
$254.60
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Cansino Biologics Inc
(OP:
CASBF
)
3.410
UNCHANGED
Delayed Quote
Updated: 3:07 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cansino Biologics Inc
CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth
October 27, 2026
From
CanSino Biologics Inc
Via
ACN Newswire
Overseas Growth Gathers Momentum as CanSinoBIO's Global Strategy Unlocks New Opportunities
August 27, 2026
From
CanSino Biologics Inc
Via
ACN Newswire
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
August 16, 2026
From
CanSino Biologics Inc
Via
ACN Newswire
CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America
June 29, 2026
Via
ACN Newswire
CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion
April 28, 2026
Via
ACN Newswire
CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader
March 30, 2026
Via
ACN Newswire
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
August 20, 2025
Via
ACN Newswire
CanSino Receives Another Strong Boost
October 09, 2024
Via
ACN Newswire
CanSinoBIO Reports Outstanding H1 2024 Performance
August 29, 2024
Via
ACN Newswire
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
February 24, 2026
From
CanSino Biologics Inc
Via
ACN Newswire
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
June 20, 2025
Via
ACN Newswire
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
March 25, 2025
Via
ACN Newswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
↗
August 12, 2023
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...
Via
Talk Markets
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
↗
November 02, 2022
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.
Via
InvestorPlace
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
↗
May 28, 2022
Fosun Pharma acquired China rights to a novel broad cancer immunotherapy candidate from VerImmune of Baltimore in an $125 million agreement. Fosun will pay VerImmune up to $125 million in upfront and...
Via
Talk Markets
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
↗
December 11, 2021
Regor Therapeutics entered a $1.55 billion research pact with Eli & Lilly to discover therapies for metabolic disorders. Meanwhile, Beijing Avistone Pharma received a $200 million investment led by...
Via
Talk Markets
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
↗
April 24, 2021
Zai Lab raised a staggering $750 million in a private placement of its dual US/Hong Kong-listed stock. It currently has a portfolio of 21 products. Zai has a market cap of $14 billion and over $1...
Via
Talk Markets
